arrow
A

Aris N. Economides

Regeneron Pharmaceuticals
H指数:73
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Functional, sustained recovery of hearing in Otoferlin-deficient mice using DB-OTO, a hair cell-specific AAV based dual vector gene therapy

使用DB-OTO(一种基于毛细胞特异性AAV的双载体基因疗法)实现 otoferlin 缺陷小鼠功能性、持续性的听力恢复

2025-08-250
OAAI
A rare variant in GPR156 associated with depression in a Mennonite pedigree causes habenula hyperactivity and stress sensitivity in mice

与门诺家族中抑郁症相关的GPR156罕见变异会导致小鼠下丘脑核过度活跃和应激敏感性。

2025-04-140
OA
Genetic inactivation of zinc transporter SLC39A5 improves liver function and hyperglycemia in obesogenic settings

锌转运蛋白SLC39A5的遗传失活可改善致肥胖环境中的肝功能和高血糖

2024-12-130
OA
Characterization of flare-ups and impact of garetosmab in adults with fibrodysplasia ossificans progressiva: a post hoc analysis of the randomized, double-blind, placebo-controlled LUMINA-1 trial
2024-08-311
OAAI
Genetic risk factors for COVID-19 and influenza are largely distinct
2024-08-050
OAAI
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial

Garetosmab治疗进行性骨化性纤维发育不良: 一项随机、双盲、安慰剂对照2期试验

2023-09-2817
OAAI
Converging evidence from exome sequencing and common variants implicates target genes for osteoporosis
2023-08-099
PRE
Antibodies to sclerostin or G-CSF receptor partially eliminate bone or marrow adipocyte loss, respectively, following vertical sleeve gastrectomy

垂直袖状胃切除术后,硬化蛋白或g-csf受体的抗体分别部分消除了骨或骨髓脂肪细胞的丢失

BONE
IF3.6
2023-04-013
OAAI
Germline Mutations in CIDEB and Protection against Liver Disease

CIDEB的种系突变和对肝脏疾病的保护

2022-07-2853
OA
Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1
2022-06-1516
OAAI
Regulation of sensorimotor gating via Disc1/Huntingtin-mediated Bdnf transport in the cortico-striatal circuit
2022-02-141
OAAI